117 completed, 29 unknown, 13 terminated, 9 recruiting. 54 Phase 2, 43 Phase 3, 33 Phase 4, 31 Not applicable, 14 Phase 1.
Follow Growth Hormone: new trials by email Literature Review of Growth Hormone trials Research Report on Growth Hormone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe Acute Brain Injury (GH-ABI-RCT) Recombinant Human Growth Hormone (rhGH) Injection, Standard Care (Treatment as Usual) - Acute Brain Injuries, Moderate to Severe Traumatic Brain Injury | Phase 4 | Not yet recruiting | Anhui Provincial Hospital | 160 | 2026-04-10 | 2026-03-19 |
| The Efficacy and Safety of Inpegsomatropin Injection in Children With Short Stature Born Small for Gestational Age Inpegsomatropin Injection, Recombinant Human Growth Hormone Injection - Small for Gestational Age | Phase 3 | Recruiting | Xiamen Amoytop Biotech Co., Ltd. | 141 | 2026-01-20 | 2026-05-08 |
| Recombinant Human Growth Hormone (rHGH) for Knee Osteoarthritis (KORR) Somatropin (recombinant human growth hormone), bacteriostatic saline placebo - Knee Osteoarthritis (Knee OA), Knee Osteoarthritis (OA) | Phase 1 / Phase 2 | Active not recruiting | Dr. David Wasserstein | 34 | 2025-10-31 | 2026-07-31 |
| Evaluating the Efficacy and Safety of GB08 Injection in Pediatric Patients With Growth Hormone Deficiency GB08, Norditropin NordiFlex - Growth Hormone Deficiency in Children, Growth Hormone Deficiency (GHD) | Phase 2 / Phase 3 | Not yet recruiting | Shenzhen Kexing Pharmaceutical Co., Ltd. | 268 | 2025-08-31 | 2025-08-22 |
| A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) GenSci134, Placebo, Recombinant Human Growth Hormone Injection (Norditropin®) - Safety, Tolerability | Phase 1 | Recruiting | Changchun GeneScience Pharmaceutical Co., Ltd. | 64 | 2025-06-09 | 2026-04-14 |
| The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature Inpegsomatropin Injection, Recombinant Human Growth Hormone Injection - Idiopathic Short Stature | Phase 3 | Recruiting | Xiamen Amoytop Biotech Co., Ltd. | 300 | 2025-04-28 | 2026-03-11 |
| Human Growth Hormone Injections in the Knee Joint to Treat Osteoarthritis Recombinant human growth hormone - Osteoarthritis, Knee | Phase 2 | Suspended | John Sledge | 23 | 2025-02-08 | 2024-10-04 |
| Growth Hormone for the Treatment of Gastroparesis Growth Hormone - Gastroparesis | Early Phase 1 | Recruiting | Mayo Clinic | 10 | 2024-10-22 | 2026-04-16 |
| Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT) Recombinant human growth hormone - Gulf War Syndrome, Adult Growth Hormone Deficiency | Phase 2 | Recruiting | Baylor College of Medicine | 20 | 2024-03-11 | 2026-05-08 |
| Randomized Clinical Trial of Two Different Initial Growth Hormone Doses in Children Somatropin - Growth Disorders, Growth Failure | Phase 3 | Recruiting | Northwell Health | 50 | 2023-12-10 | 2026-10-21 |
| Short Stature and Psychological Well-being Recombinant human growth hormone (only for children with growth hormone deficiency) - Short Stature, Short; Stature, Psychosocial | Completed | Istituto Auxologico Italiano | 80 | 2023-05-10 | 2025-04-30 | |
| Effects of GH and Lirglutide on AgRP growth hormone and lirglutide, growth hormone, liraglutide - Healthy, Growth Hormone Deficiency | Phase 4 | Recruiting | Columbia University | 40 | 2023-05-01 | 2026-03-04 |
| Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury Electrical stimulation, Growth hormone (somatropin), Control (No electrical stimulation, nor growth hormone) - Muscle Injury | Not applicable | Recruiting | Bispebjerg Hospital | 40 | 2023-02-24 | 2025-09-24 |
| Growth Hormone Deficiency in Mild Traumatic Brain Injury Growth Hormone, Placebo - Growth Hormone Treatment, Growth Hormone Deficiency | Early Phase 1 | Unknown | University of Calgary | 20 | 2023-02-01 | 2022-12-21 |
| Growth Hormone to Improve the Clinical Outcome of Assisted Fertility in Young Patients With Decreased Ovarian Reserve Growth hormone - Infertility | Not applicable | Unknown | Nanjing University | 120 | 2022-11-01 | 2022-10-24 |
| A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone in Children With Achondroplasia Recombinant human growth hormone - Achondroplasia | Phase 4 | Completed | Changchun GeneScience Pharmaceutical Co., Ltd. | 39 | 2022-08-20 | 2026-08-06 |
| Effect of GH on the Blastocyst Euploid Rate in AMA Patients Growth Hormone, GnRH antagonist - Preimplantation Genetic Testing, Growth Hormone | Phase 3 | Recruiting | ShangHai Ji Ai Genetics & IVF Institute | 400 | 2022-08-01 | 2025-02-12 |
| Growth Hormone For Poor Ovarian Reserve Patients in ICSI Trials 4 IU of recombinant GH (Somatotropin ) - Poor Ovarian Reserve | Phase 2 / Phase 3 | Unknown | Beni-Suef University | 120 | 2022-02-01 | 2023-04-28 |
| Growth Hormone in Decompensated Liver Cirrhosis Growth Hormone - Liver Cirrhosis, Fibrosis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 96 | 2022-02-01 | 2025-12-16 |
| A Controlled Trial of Growth Hormone in Phelan-McDermid Syndrome and Idiopathic Autism Growth Hormone, Saline - Phelan-McDermid Syndrome, Autism Spectrum Disorder (ASD) | Phase 2 | Completed | Icahn School of Medicine at Mount Sinai | 32 | 2022-01-19 | 2025-04-20 |
Showing 20 of 183. Sign in to see all of them.
Dwarfism, Pituitary (44) · Dwarfism (15) · Insulin Resistance (11) · Turner Syndrome (10) · HIV Infections (7) · Metabolic Syndrome (6) · Rare Diseases (6) · Cystic Fibrosis (5) · Hypopituitarism (5) · Infertility (5) · Infertility, Female (5) · Kidney Failure, Chronic (5) · Prader-Willi Syndrome (5) · Brain Injuries, Traumatic (4) · Failure to Thrive (4)
Massachusetts General Hospital (9) · University of Aarhus (9) · Changchun GeneScience Pharmaceutical Co., Ltd. (7) · Eli Lilly and Company (6) · Federico II University (6) · Columbia University (5) · EMD Serono (5) · Merck KGaA, Darmstadt, Germany (5) · The University of Texas Medical Branch, Galveston (5) · Oregon Health and Science University (4) · Post Graduate Institute of Medical Education and Research, Chandigarh (4) · Baylor College of Medicine (3) · Genentech, Inc. (3) · National Center for Research Resources (NCRR) (3) · Nemours Children's Clinic (3)
United States (76) · China (17) · Denmark (14) · Egypt (12) · Italy (11) · France (8) · Germany (8) · Spain (8) · Canada (6) · India (4) · Sweden (3) · United Kingdom (3) · Belgium (2) · Czechia (2) · Greece (2)
Dina M Dakhly, MD (3) · Nelly Mauras, MD (3) · Alexander Kolevzon, MD (2) · Anne Klibanski, MD (2) · Dana S Hardin, MD (2) · Doug Vaughan, MD (2) · Kevin C. Yuen, MRCP(UK), MD (2) · Lynne L Levitsky, MD (2) · Pamela U. Freda, MD (2) · Xiaoping Luo, Ph.D (2)
PMID 34808697, PMID 22606232, PMID 26921622, PMID 10022400, PMID 10199767, PMID 10199774, PMID 10372687, PMID 11207626, PMID 11273062, PMID 11344175, PMID 11531927, PMID 11739090, PMID 11889170, PMID 12924350, PMID 14678952, PMID 15076238, PMID 15126541, PMID 15213282, PMID 15355453, PMID 15579750, PMID 15585563, PMID 15671089, PMID 15756212, PMID 15784709, PMID 15985481, PMID 16444180, PMID 16690338, PMID 16757526, PMID 17579195, PMID 18292808, PMID 18292816, PMID 18593773, PMID 18677023, PMID 18791359, PMID 19240154, PMID 19366847, PMID 19734776, PMID 1973979, PMID 20061426, PMID 20372873, PMID 20395554, PMID 20598930, PMID 20701787, PMID 20739853, PMID 20881067, PMID 21449786, PMID 21490076, PMID 21543424, PMID 21543538, PMID 21619701
P50GM060338 (2), R01DK063639 (2), 2004 (1), 2005 (1), 2008 (1), 2017 (1), R01AG018169 (1), R01AI043864 (1), R01DK055850 (1), R01DK065515 (1), R01DK110771 (1), R01GM056687 (1), R01NS105845 (1)